Results 121 to 130 of about 32,135 (260)

Safety and Feasibility of Magnetic Separation‐Based Blood Purification

Advanced NanoBiomed Research, EarlyView.
We present the preclinical biological safety and translational feasibility of a magnetic nanoparticle‐based extracorporeal blood purification platform for removal of disease‐causing blood factors. ISO 10993‐compliant studies and exaggerated worst‐case exposure models demonstrate efficient nanoparticle extraction (≥99.9%), favorable biocompatibility ...
Carlos A. Mora, Laurine Rijsbergen, Jan Waskowski, Gaelle Clermont, Florian Dingreville, Chandrashekara Vishwanath, Rajesh Karunanithi, Alexander Gogos, Jean‐Claude Metzger, Manuel Baumgartner, Joerg C. Schefold, Inge K. Herrmann   +11 more
wiley   +1 more source

Risk mitigation for vaccine-preventable diseases in the dental clinic. [PDF]

Germs, 2023
Săndulescu O, Săndulescu M.
europepmc   +1 more source

Letter to the Editor

Canadian Journal of Infectious Diseases and Medical Microbiology, 2013
Michelle Shuel, Raymond SW Tsang
doaj   +1 more source

Global burden and time trends of vaccine-preventable diseases in children and adolescents. [PDF]

Ital J Pediatr
Jin X, Wang R, Tu S, Yuan C, Ge F, Liu Y, Wang S, Ma Y, Sun G.   +8 more
europepmc   +1 more source

Measles Resurgence in Europe: An Open Breakthrough in the Field of Vaccine-Preventable Diseases. [PDF]

Pathogens, 2023
De Francesco MA.
europepmc   +1 more source

Vaccine cold chain and understanding what underpins vaccine security for vaccine preventable diseases. [PDF]

BMJ Med
Rukundo G, Moore M, Semukunzi H, Chatterjee S, Musabyimana JP, Mambo Muvunyi C, Green CA.   +6 more
europepmc   +1 more source

Entangled epidemics: tackling vaccine-preventable diseases in the era of frequent epidemics in Africa. [PDF]

Pan Afr Med J, 2023
Kouamou V, Inzaule S.
europepmc   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

Angewandte Chemie International Edition, EarlyView.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber, Aina Valenti, Jiří Ledvinka, Oren Moscovitz, Peter H. Seeberger   +4 more
wiley   +1 more source

Seroprotection to five vaccine-preventable diseases among children in East New Britain, Papua New Guinea. [PDF]

Lancet Reg Health West Pac
Vaccher S, Ome-Kaius M, Mantila D, Rakuafery D, Dalton M, Valaki C, Melepia P, Kiromat P, Stanley E, Waramin E, Scoullar MJL, Laman M, Angrisano F, Robinson LJ.   +13 more
europepmc   +1 more source

Differential effects of therapeutic complement inhibitors on serum bactericidal activity against non-groupable meningococcal isolates recovered from patients treated with eculizumab

Haematologica, 2019
Dan M. Granoff, Howard Kim, Nadav Topaz, Jessica MacNeil, Xin Wang, Lucy A. McNamara   +5 more
doaj   +1 more source